UBS O'Connor’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.21M | Sell |
81,251
-9,528
| -10% | -$376K | 0.16% | 92 |
|
2025
Q1 | $2.74M | Buy |
90,779
+30,199
| +50% | +$911K | 0.08% | 90 |
|
2024
Q4 | $2.12M | Buy |
60,580
+23,623
| +64% | +$826K | 0.06% | 147 |
|
2024
Q3 | $1.48M | Sell |
36,957
-5,638
| -13% | -$226K | 0.04% | 220 |
|
2024
Q2 | $2.03M | Buy |
42,595
+183
| +0.4% | +$8.72K | 0.06% | 187 |
|
2024
Q1 | $1.84M | Buy |
42,412
+13,788
| +48% | +$598K | 0.05% | 185 |
|
2023
Q4 | $1.45M | Sell |
28,624
-33,435
| -54% | -$1.69M | 0.05% | 223 |
|
2023
Q3 | $2.81M | Sell |
62,059
-10,000
| -14% | -$454K | 0.05% | 184 |
|
2023
Q2 | $2.96M | Sell |
72,059
-35,430
| -33% | -$1.45M | 0.06% | 193 |
|
2023
Q1 | $3.84M | Buy |
+107,489
| New | +$3.84M | 0.09% | 178 |
|
2022
Q4 | – | Sell |
-54,497
| Closed | -$2.41M | – | 156 |
|
2022
Q3 | $2.41M | Sell |
54,497
-7,000
| -11% | -$310K | 0.03% | 510 |
|
2022
Q2 | $2.28M | Buy |
+61,497
| New | +$2.28M | 0.02% | 617 |
|
2020
Q1 | – | Sell |
-57,636
| Closed | -$3.48M | – | 301 |
|
2019
Q4 | $3.48M | Buy |
+57,636
| New | +$3.48M | 0.1% | 163 |
|
2014
Q2 | – | Hold |
0
| – | – | – | 457 |
|
2014
Q1 | – | Hold |
0
| – | – | – | 433 |
|
2013
Q4 | – | Hold |
0
| – | – | – | 392 |
|
2013
Q3 | – | Hold |
0
| – | – | – | 424 |
|